5-Fluoro-DET

5-Fluoro-DET
Clinical data
Other names	5-F-DET; 5-Fluoro-N,N-diethyltryptamine;
Identifiers
	IUPAC name N,N-diethyl-2-(5-fluoro-1H-indol-3-yl)ethanamine;
PubChem CID	49856188;
ChemSpider	26381379;
ChEMBL	ChEMBL1630730;
Chemical and physical data
Formula	C14H19FN2
Molar mass	234.318 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES CCN(CC)CCC1=CNC2=C1C=C(C=C2)F;
	InChI InChI=1S/C14H19FN2/c1-3-17(4-2)8-7-11-10-16-14-6-5-12(15)9-13(11)14/h5-6,9-10,16H,3-4,7-8H2,1-2H3; Key:LBJIPBJDJFZKIQ-UHFFFAOYSA-N;

5-Fluoro-DET (5F-DET, 5-fluoro-N,N-diethyltryptamine) is a tryptamine derivative related to drugs such as DET and 5-MeO-DET.^[1]^[2] It acts as an inhibitor of the enzyme myeloperoxidase,^[3] and is also thought to be an agonist at the 5-HT_2A receptor.^[4]

References

^ Pelchowicz Z, Kaluszyner A, Bentov M (1961). "1067. N-alkylated 5-fluorotryptamines". Journal of the Chemical Society (Resumed): 5418–5421. doi:10.1039/JR9610005418.
^ Kalir A, Szara S (May 1966). "Synthesis and pharmacological activity of alkylated tryptamines". Journal of Medicinal Chemistry. 9 (3): 341–4. doi:10.1021/jm00321a017. PMID 5960901.
^ Soubhye J, Prévost M, Van Antwerpen P, Zouaoui Boudjeltia K, Rousseau A, Furtmüller PG, Obinger C, Vanhaeverbeek M, Ducobu J, Néve J, Gelbcke M, Dufrasne FO (December 2010). "Structure-based design, synthesis, and pharmacological evaluation of 3-(aminoalkyl)-5-fluoroindoles as myeloperoxidase inhibitors" (PDF). Journal of Medicinal Chemistry. 53 (24): 8747–59. doi:10.1021/jm1009988. PMID 21090682. S2CID 207225972.
^ WO 2021/168082, Kruegel AC, Sporn J, "Specific Tryptamines for use in the Treatment of Mood Disorders.", published 26 August 2021, assigned to Gilgamesh Pharmaceuticals, Inc..

This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it.